Together, these findings identified a key role of the ALCAT1 enzyme in MPTP‐induced neurotoxicity, suggesting that targeting ALCAT1 with molecule inhibitors may provide a novel treatment for PD, a debilitating disease without any effective treatment. Here, LCLAT1 is linked to Parkinson disease.